Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
R. Turpin, K. Peltonen, J. H. Rannikko, R. Liu, A. N. Kumari, D. Nicorici, M. H. Lee, M. Mutka, P. E. Kovanen, L. Niinikoski, T. Meretoja, J. Mattson, P. Järvinen, K. Lahdensuo, R. Järvinen, , J. Klefström
The paper evaluates immunomodulatory drug responses in patient-derived tumor explant models of breast and renal cancer, finding reproducible gene expression and cytokine changes across models.
bioRxiv · May 11, 2024Immunology